WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BIOTECHNOLOGY INSTITUTE, founded in 2002, is a small nonprofit in the Diseases & Disorders sector that reported $776K in total revenue in fiscal year 2021. Revenue surged 82% from the prior year, signaling strong growth momentum. The organization ran a surplus of $264K, a strong 34% operating margin.
THE BIOTECHNOLOGY INSTITUTE HAS SET A COURSE TO BE THE RECOGNIZED LEADER IN BIOTECHNOLOGY EDUCATION AT THE NATIONAL LEVEL. ITS MISSION IS TO EDUCATE THE PUBLIC THROUGH PARTNERSHIPS WITH LOCAL, REGIONAL, STATE AND NATIONAL EDUCATIONAL INITIATIVES TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE PROMISE, ACHIEVEMENTS AND CHALLENGES OF BIOTECHNOLOGY. THE FOCUS IS ACTIVE SUPPORT FOR TEACHERS AND STUDENTS, ESPECIALLY IN THE UNITED STATES, TO PURSUE STUDIES, TRAINING, AND CAREERS IN BIOTECHNOLOGY FROM PRE-COLLEGE THROUGH GRADUATE YEARS.
NETWORK BY WORKING WITH AND THROUGH STATE ORGANIZATIONS, HAS HAD GREAT SUCCESS. THE RESULT OF OUR PARTNERSHIPS HAS BEEN A DRAMATIC INCREASE IN THE NUMBER OF BIOGENEIUS PARTICIPANTS. THE 2021...
NETWORK BY WORKING WITH AND THROUGH STATE ORGANIZATIONS, HAS HAD GREAT SUCCESS. THE RESULT OF OUR PARTNERSHIPS HAS BEEN A DRAMATIC INCREASE IN THE NUMBER OF BIOGENEIUS PARTICIPANTS. THE 2021 INTERNATIONAL EVENTS TOOK PLACE IN CONJUNCTION WITH THE BIO INTERNATIONAL CONVENTION (JUNE 10-18, 2021, VIRTUAL PLATFORM). WE HAD GREAT SUCCESS PROVIDING VIRTUAL SCIENCE COURSES TO ELEMENTARY AND MIDDLE SCHOOL STUDENTS FROM UNDER RESOURCED POPULATIONS DURING THE PANDEMIC.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2021 | 2020 | Change | |
|---|---|---|---|
| Revenue | $775,500 | $425,000 | +0.8% |
| Expenses | $511,266 | $303,325 | +0.7% |
| Net Income | $264,234 | $121,675 | +1.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JAMES GREENWOOD | CHAIRMAN | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| HEIDI JARVIS GRIMES | TREASURER | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| LECIA BROWN | BOARD MEMBER | 4.00 |
Director
|
$0 | $0 | $0 |
| LAWRENCE MAHAN | PRESIDENT | 30.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2021 | $775,500 | $511,266 | $332,875 | $264,234 |
| 2020 | $425,000 | $303,325 | $92,812 | $121,675 |
| 2019 | $550,000 | $492,465 | $105,674 | $57,535 |
| 2018 | $500,000 | $537,538 | $68,180 | $-37,538 |
Compare BIOTECHNOLOGY INSTITUTE with other nonprofits in District of Columbia and across the country.